Sam Burgess
Associate
London, UK
Sam Burgess is an associate actuary within Milliman's Life Practice in London.
Experience
Sam joined Milliman in April 2020.
Education
- MMath, Mathematics, Warwick University
Publications
Read their latest work
Article
世界の生命保険および健康保険のM&A：2025年
15 May 2025 - by Ian Humphries, Katie Nelson, Tanner McKerlie, Chew Hou Ng, Sam Burgess, Stuart Reynolds, Ariel Hojman, Fernando Mesquida, Richard Taylor, David Kirk, Su Meng Lee
北米、欧州、アジア、中南米、アフリカでの取引について、2024年のレビューと2025年以降の見通しをお伝えします。
Article
Analysing 2023 Solvency and Financial Condition Reports (SFCR) of life insurers in Europe and the UK
02 October 2024 - by Sam Burgess, Neil Christy, Yuliia Maznytsia, Diya Pittie, Isabel Stansfield
Our analysis covering Europe and the UK dives into life insurer SFCRs for year-end 2023, including key financial information from the quantitative reporting templates.
Article
欧州における株主価値の報告：ソルベンシーIIに基づく指標
16 September 2024 - by Sam Burgess, David Burston, Tatiana Egoshina, Andrew Kirk, Chew Hou Ng, Stuart Reynolds, Isabel Stansfield, Lyndsay Wrobel
ミリマンの2024年サマリー版年次報告では、ソルベンシーIIに基づく指標の昨年の結果について詳述し、報告における主要なテーマについて考察します。
Article
Global life and health insurance mergers and acquisitions (M&A)
16 April 2024 - by Ian Humphries, Katie Nelson, Tanner McKerlie, Chew Hou Ng, Sam Burgess, Lyndsay Wrobel, Stuart Reynolds, Ariel Hojman, Fernando Mesquida
Globally, 80 life and health insurance mergers and acquisitions were announced in 2023, down from 131 in 2022. However, total publicly announced deal values rose from US$20.4 billion in 2022 to US$21.5 billion in 2023.
Article
Shareholder value reporting in Europe: Solvency II based metrics
13 November 2023 - by Sam Burgess, Tatiana Egoshina, Stuart Reynolds, Isabel Stansfield, Lyndsay Wrobel
This report summarises the annual research performed by Milliman which looks at Solvency II based metrics for a sample of over 20 firms in Europe based on disclosures at year-end 2022.
Article
欧州および英国の生命保険会社のソルベンシーおよび財務状況報告書の分析：2022年末
26 September 2023 - by Sam Burgess, Neil Christy, Isabel Stansfield
英国の生命保険会社は、2022年末SFCRsにて健全な結果を報告し、欧州の生命保険会社は、SCRカバー率の全般的上昇を報告しました。
Article
世界の生命保険および健康保険会社のM&A：2023年
03 August 2023 - by Ian Humphries, Sam Burgess, Katie Nelson, Tubin Wang, Candace Wang, John Gakuya, Stuart Reynolds
2022年、生命保険および健康保険の取引は激減しました。ミリマンでは、その考えられる原因について考察し、今後のM&Aの状況を展望します。
Article
欧州における株主価値の報告：ソルベンシーIIに基づく測定基準
21 March 2023 - by Sam Burgess, Stuart Reynolds, Lyndsay Wrobel
ポストコロナの環境において、欧州保険会社の2021年の業績報告から導かれる重要テーマについて考察します。
Article
Analysis of life insurers' solvency and financial condition reports year-end 2021
18 October 2022 - by Sam Burgess, Neil Christy, Stuart Reynolds, Isabel Stansfield
Our analysis covering Europe and the U.K. dives into SFCRs from year-end 2021, including key financial information contained in the reports’ QRTs.
Article
Shareholder Value Reporting in Europe - Solvency II Based Metrics
30 November 2021 - by Sam Burgess, Stuart Reynolds, Lyndsay Wrobel
We consider the impact of the pandemic to firms’ supplementary reporting metrics, and their level of Solvency II Own Funds and solvency positions.